Zurex Pharma Stock
Zurex Pharma develops a portfolio of antimicrobial products designed to prevent healthcare acquired infections.
Sign up today and learn more about Zurex Pharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Zurex Pharma Stock
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.
Funding History
| May 2011 | $1.0M |
|---|---|
| May 2012 | $6.2M |
| July 2013 | $846K |
| July 2014 | $4.1M |
| August 2016 | $6.2M |
| June 2018 | $9.0M |
| June 2020 | $7.5M |
Management
Co-Founder ,President & CEO
Carmine J. Durham
Chief Financial Officer
Alex M. Kasper
Executive Vice President, Regulatory Affairs and Quality Operations
Andrew Morgan
Board of Directors
Gary J. Sherman
Chairman & Board of Directors
Robert B. Truitt
Board of Directors
Michael Liang
Board of Directors
Gary J. Lehman
Board of Directors
Frederick Robertson
Press
wisconsintechnologycouncil - Sep, 28 2018
W I S C O N S I N P O RT F O L I Obusinesswire - Jun, 15 2018
Zurex Pharma, Inc. Announces Capital Raise of $9,000,000 In Advance Of Pending New Drug Application Submissionxconomy - Jun, 13 2018
Zurex Pharma Raises $9M to Fight Hospital-Acquired Infectionsxconomy - Oct, 31 2016
Zurex Pharma’s Antimicrobial Attracts $6.2M for Clinical Trialxconomy - Jul, 3 2014
Zurex Pharma Raises $4M to Battle Hospital-Acquired Infections | XconomyEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
